Christine Bodemer

Christine Bodemer

Paris, France

ESPD Guest Lecture

Title: Understanding human epidermis at single cell resolution

Date: Saturday 5 September 2020, 09.30-10.00


Professor Christine Bodemer (MD, PhD) is the head of the Department of Dermatology at the Necker Enfants- Malades Hospital, Paris, France. She received her PhD on Cutaneous Biology in 1997, a qualification to direct Research in 2000, and she is Professor in Dermatology at the Paris Descartes-Sorbonne Paris Centre University since 2001. She is regularly invited to give lecture in international congresses and is more particularly specialized in Pediatric dermatology. Professor Bodemer has published more than 400 articles in international Journals, and contributed to major textbooks of Pediatric dermatology as author. One of her main fields of interest concerns rare skin disorders in children and she coordinates a national certified centre for rare pediatric skin diseases (mostly Genodermatoses, Mastocytoses, Toxic dermatoses) (MAGEC) , the French national network (FIMARAD) and European network (ERN-SKIN) for rare skin diseases.

Selected Publications

Use of Epidermal Growth Factor Receptor Inhibitor Erlotinib to Treat Palmoplantar Keratoderma in Patients With Olmsted Syndrome Caused by TRPV3 Mutations. Greco C, Leclerc-Mercier S, Chaumon S, Doz F, Hadj-Rabia S, Molina T, Boucheix C, Bodemer C. JAMA Dermatol. 2020 Jan 2. doi: 10.1001/jamadermatol.2019.

Palmoplantar keratoderma: creating a disease burden questionnaire. Hickman G, Bodemer C, Bourrat E, Bennani M, Taieb C. J Eur Acad Dermatol Venereol. 2019 Aug;33(8):e291-e293.

Consensus re-classification of inherited epidermolysis bullosa and other disorders with skin fragility. Has C, Bauer JW, Bodemer C, Bolling M, Bruckner-Tuderman L, Diem A, Fine JD, Heagerty A, Hovnanian A, Marinkovich P, Martinez AE, McGrath JA, Moss C, Murrell DF, Palisson F, Schwieger-Briel A, Sprecher E, Tamai K, Uitto J, Woodley DT, Zambruno G, Mellerio JE. Br J Dermatol. 2020 Feb 4. doi: 10.

Review. Impact of a rare chronic genodermatosis on family daily life: the example of epidermolysis bullosa.Dufresne H, Hadj-Rabia S, Bodemer C. Br J Dermatol. 2018 Nov;179(5):1177-1178.

Development and validation of an epidermolysis bullosa family/parental burden score. Dufresne H, Hadj-Rabia S, Taieb C, Bodemer C. Br J Dermatol. 2015 Dec;173(6):1405-10.

Epithelial barrier dysfunction in desmoglein-1 deficiency. Polivka L, Hadj-Rabia S, Bal E, Leclerc- Mercier S, Madrange M, Hamel Y, Bonnet D, Mallet S, Lepidi H, Ovaert C, Barbet P, Dupont C, Neven B, Munnich A, Godsel LM, Campeotto F, Weil R, Laplantine E, Marchetto S, Borg JP, Weis WI, Casanova JL, Puel A, Green KJ, Bodemer C and Smahi A. J Allergy Clin Immunol. 2018 Aug;142(2):702-706.

Eosinophilic esophagitis and colonic mucosal eosinophilia in Netherton syndrome. Paluel-Marmont C, Bellon N, Barbet P, Leclerc-Mercier S, Hadj-Rabia S, Dupont C, Bodemer C. J Allergy Clin Immunol. 2017

Paediatric mastocytosis: long-term follow-up of 53 patients with whole sequencing of KIT. A prospective study. Meni C, Georgin-Lavialle S, Le Saché de Peufeilhoux L, Jais JP, Hadj-Rabia S, Bruneau J, Fraitag S, Hanssens K, Dubreuil P, Hermine O, Bodemer C. Br J Dermatol. 2018 Oct;179(4):925-932

Paediatric mastocytosis: a systematic review of 1747 cases. Méni C, Bruneau J, Georgin-Lavialle S, Le Saché de Peufeilhoux L, Damaj G, Hadj-Rabia S, Fraitag S, Dubreuil P, Hermine O, Bodemer C. Br J Dermatol. 2015 Mar;172(3):642-51.

Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. Bodemer C, Hermine O, Palmérini F, Yang Y, Grandpeix-Guyodo C, Leventhal PS, Hadj- Rabia S, Nasca L, Georgin-Lavialle S, Cohen-Akenine A, Launay JM, Barete S, Feger F, Arock M, Catteau B, Sans B, Stalder JF, Skowron F, Thomas L, Lorette G, Plantin P, Bordigoni P, Lortholary O, de Prost Y, Moussy A, Sobol H, Dubreuil P. J Invest Dermatol. 2010;130: 804-15.

Live rubella virus vaccine long-term persistence as an antigenic trigger of cutaneous granulomas in patients with primary immunodeficiency. Bodemer C, Sauvage V, Mahlaoui N, Cheval J, Couderc T, Leclerc-Mercier S, Debré M, Pellier I, Gagnieur L, Fraitag S, Fischer A, Blanche S, Lecuit M, Eloit M. Clin Microbiol Infect. 2014; 20):O656-63